Transcatheter Aortic Valve Replacement - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Why and How to Measure Aortic Valve Calcification in Patients With Aortic Stenosis
Infective endocarditis after transcatheter aortic valve implantation: a nationwide study
Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart Disease
Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte Activation
Minimalist transcatheter aortic valve replacement: The new standard for surgeons and cardiologists using transfemoral access?
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement
Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement
Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement

Review Article

2021 Mar, 77 (10) 1344–1356

JOURNAL：J Am Coll Cardiol.

Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review

G Muntané-Carol , F Philippon , I Nault et al.

2965

Keywords: TAVR; ambulatory electrocardiogram monitoring

ABSTRACT

Transcatheter aortic valve replacement (TAVR) has changed the treatment of patients with severe aortic stenosis. However, the occurrence of conduction disturbances has not decreased significantly over time and remains the main drawback of the procedure. In addition, new-onset atrial fibrillation is the most frequent tachyarrhythmia during the hospitalization period and is associated with worse clinical outcomes. However, little is known regarding the incidence and clinical impact of arrhythmic events beyond the periprocedural TAVR period. Ambulatory electrocardiogram (AECG) monitoring has recently emerged as a tool to unravel the complex issue of arrhythmic disorders (bradyarrhythmias and tachyarrhythmias) before and after TAVR. To date, the preliminary results from the initial experience using AECG monitoring systems showed the safety, usefulness, and potential clinical implications of this diagnostic tool in TAVR recipients. This review provides an overview of the current status, clinical implications, and future perspectives of AECG monitoring in the TAVR setting.